These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 17293363

  • 1. Endothelial progenitor cells in active rheumatoid arthritis: effects of tumour necrosis factor and glucocorticoid therapy.
    Grisar J, Aletaha D, Steiner CW, Kapral T, Steiner S, Säemann M, Schwarzinger I, Buranyi B, Steiner G, Smolen JS.
    Ann Rheum Dis; 2007 Oct; 66(10):1284-8. PubMed ID: 17293363
    [Abstract] [Full Text] [Related]

  • 2. Effect of anti-TNFalpha treatment on circulating endothelial progenitor cells (EPCs) in rheumatoid arthritis.
    Ablin JN, Boguslavski V, Aloush V, Elkayam O, Paran D, Caspi D, George J.
    Life Sci; 2006 Nov 17; 79(25):2364-9. PubMed ID: 16962143
    [Abstract] [Full Text] [Related]

  • 3. Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis.
    Grisar J, Aletaha D, Steiner CW, Kapral T, Steiner S, Seidinger D, Weigel G, Schwarzinger I, Wolozcszuk W, Steiner G, Smolen JS.
    Circulation; 2005 Jan 18; 111(2):204-11. PubMed ID: 15642766
    [Abstract] [Full Text] [Related]

  • 4. Anti-TNF antibody treatment improves glucocorticoid induced insulin-like growth factor 1 (IGF1) resistance without influencing myoglobin and IGF1 binding proteins 1 and 3.
    Sarzi-Puttini P, Atzeni F, Schölmerich J, Cutolo M, Straub RH.
    Ann Rheum Dis; 2006 Mar 18; 65(3):301-5. PubMed ID: 16079165
    [Abstract] [Full Text] [Related]

  • 5. Long-term anti-tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretion.
    Straub RH, Pongratz G, Schölmerich J, Kees F, Schaible TF, Antoni C, Kalden JR, Lorenz HM.
    Arthritis Rheum; 2003 Jun 18; 48(6):1504-12. PubMed ID: 12794817
    [Abstract] [Full Text] [Related]

  • 6. Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis.
    Tsujimura S, Saito K, Nawata M, Nakayamada S, Tanaka Y.
    Ann Rheum Dis; 2008 Mar 18; 67(3):380-8. PubMed ID: 17660216
    [Abstract] [Full Text] [Related]

  • 7. Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis.
    Popa C, Netea MG, Radstake T, Van der Meer JW, Stalenhoef AF, van Riel PL, Barerra P.
    Ann Rheum Dis; 2005 Feb 18; 64(2):303-5. PubMed ID: 15231512
    [Abstract] [Full Text] [Related]

  • 8. Neutrophils of rheumatoid arthritis patients on anti-TNF-α therapy and in disease remission present reduced adhesive functions in association with decreased circulating neutrophil-attractant chemokine levels.
    Dominical VM, Bértolo MB, Almeida CB, Garrido VT, Miguel LI, Costa FF, Conran N.
    Scand J Immunol; 2011 Apr 18; 73(4):309-18. PubMed ID: 21208248
    [Abstract] [Full Text] [Related]

  • 9. Endothelial dysfunction in patients with rheumatoid arthritis is associated with a reduced number and impaired function of endothelial progenitor cells.
    Herbrig K, Haensel S, Oelschlaegel U, Pistrosch F, Foerster S, Passauer J.
    Ann Rheum Dis; 2006 Feb 18; 65(2):157-63. PubMed ID: 15975971
    [Abstract] [Full Text] [Related]

  • 10. Relationship of serum TWEAK level to cytokine level, disease activity, and response to anti-TNF treatment in patients with rheumatoid arthritis.
    Park MC, Chung SJ, Park YB, Lee SK.
    Scand J Rheumatol; 2008 Feb 18; 37(3):173-8. PubMed ID: 18465450
    [Abstract] [Full Text] [Related]

  • 11. Vascular endothelial function and circulating endothelial progenitor cells in patients with cardiac syndrome X.
    Huang PH, Chen YH, Chen YL, Wu TC, Chen JW, Lin SJ.
    Heart; 2007 Sep 18; 93(9):1064-70. PubMed ID: 17488770
    [Abstract] [Full Text] [Related]

  • 12. Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis.
    Popa C, van den Hoogen FH, Radstake TR, Netea MG, Eijsbouts AE, den Heijer M, van der Meer JW, van Riel PL, Stalenhoef AF, Barrera P.
    Ann Rheum Dis; 2007 Nov 18; 66(11):1503-7. PubMed ID: 17472994
    [Abstract] [Full Text] [Related]

  • 13. Tumour necrosis factor antagonists improve disease activity but not arterial stiffness in rheumatoid arthritis.
    Van Doornum S, McColl G, Wicks IP.
    Rheumatology (Oxford); 2005 Nov 18; 44(11):1428-32. PubMed ID: 16076882
    [Abstract] [Full Text] [Related]

  • 14. Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis: effects of tumor necrosis factor-alpha blockade.
    Ingegnoli F, Fantini F, Favalli EG, Soldi A, Griffini S, Galbiati V, Meroni PL, Cugno M.
    J Autoimmun; 2008 Sep 18; 31(2):175-9. PubMed ID: 18707846
    [Abstract] [Full Text] [Related]

  • 15. Sex hormone concentrations in patients with rheumatoid arthritis are not normalized during 12 weeks of anti-tumor necrosis factor therapy.
    Straub RH, Härle P, Atzeni F, Weidler C, Cutolo M, Sarzi-Puttini P.
    J Rheumatol; 2005 Jul 18; 32(7):1253-8. PubMed ID: 15996060
    [Abstract] [Full Text] [Related]

  • 16. Effects of dexamethasone on lymphocyte proliferation and cytokine production in rheumatoid arthritis.
    De A, Blotta HM, Mamoni RL, Louzada P, Bertolo MB, Foss NT, Moreira AC, Castro M.
    J Rheumatol; 2002 Jan 18; 29(1):46-51. PubMed ID: 11824970
    [Abstract] [Full Text] [Related]

  • 17. Modulatory effects of inflammation and therapy on GDF-5 expression in rheumatoid arthritis synovium.
    Bramlage CP, Kaps C, Ungethüm U, Bramlage P, Koziolek M, Wessels J, Krenn V, Pruss A, Müller GA, Strutz F, Burmester GR, Häupl T.
    Scand J Rheumatol; 2008 Jan 18; 37(6):401-9. PubMed ID: 18830904
    [Abstract] [Full Text] [Related]

  • 18. Effects of granulocyte colony simulating factor on functional activities of endothelial progenitor cells in patients with chronic ischemic heart disease.
    Honold J, Lehmann R, Heeschen C, Walter DH, Assmus B, Sasaki K, Martin H, Haendeler J, Zeiher AM, Dimmeler S.
    Arterioscler Thromb Vasc Biol; 2006 Oct 18; 26(10):2238-43. PubMed ID: 16902165
    [Abstract] [Full Text] [Related]

  • 19. Tumour necrosis factor {alpha} blockade reduces circulating N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis: results from a prospective cohort study.
    Peters MJ, Welsh P, McInnes IB, Wolbink G, Dijkmans BA, Sattar N, Nurmohamed MT.
    Ann Rheum Dis; 2010 Jul 18; 69(7):1281-5. PubMed ID: 19934107
    [Abstract] [Full Text] [Related]

  • 20. Endothelial progenitor cells and colony-forming units in rheumatoid arthritis: association with clinical characteristics.
    Egan CG, Caporali F, Garcia-Gonzalez E, Galeazzi M, Sorrentino V.
    Rheumatology (Oxford); 2008 Oct 18; 47(10):1484-8. PubMed ID: 18682413
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.